Skip to main content
PEPG
NASDAQ Life Sciences

RA Capital Buys $43.1M of PepGen Stock at the $5.00 Offering Price

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$3.89
Mkt Cap
$268.734M
52W Low
$1.31
52W High
$7.8
52W Position info
197% above low
Off High info
50% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

PEPG has more than doubled off its 52-week low of $1.31.

Summary

RA Capital, a PepGen director and 10% owner, bought 8,625,000 shares at $5.00 for $43.1M — about a third of the company's $125M offering — lifting its combined holdings to 27,179,273 shares.


Key Events · Ownership and Investor Activity · PEPG

  • RA Capital Takes $43.1M of Offering

    RA Capital Healthcare Fund bought 8,625,000 shares at $5.00 on 2026-11-13 for $43,125,000 — 8,625,000 x $5.00 = $43,125,000.

  • Roughly a Third of the Deal

    The purchase covers 8,625,000 of the 25 million shares in PepGen's $125M offering priced 2026-11-12, leaving less new stock in other hands.

  • Holdings Rise to 27.2M Shares

    Post-transaction holdings total 27,179,273 shares across the Fund, Nexus Fund II and a separately managed account.

  • Entry Above Current Quote

    The $5.00 purchase price is above today's $3.89 stock price, so the new position is already below cost.


Analysis · PEPG · Life Sciences

RA Capital, a director and 10% owner, put $43.1M of its own money into PepGen's just-priced $125M offering, taking 8,625,000 of the 25 million shares at $5.00 each. That is roughly a third of the entire deal absorbed by one related party, which removes a large chunk of the new-share overhang and shows the fund backing the company right after the positive FREEDOM2-DM1 data. The purchase price is above today's $3.89 quote, so the position is already underwater on paper — the conviction is in the size, not the entry point. Post-transaction, RA Capital entities hold 27,179,273 shares.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PEPG was trading at $3.89 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $268.7M. The 52-week trading range was $1.31 to $7.80. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PEPG - Latest Insights

PEPG
Nov 11, 2026, 10:22 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $5.35
Real-time Price: $4.07 info
Change: -$1.28 (-24%) info
Market Cap: $268.734M info
PEPG
Nov 10, 2026, 4:23 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $4.89
Real-time Price: $4.07 info
Change: -$0.815 (-17%) info
Market Cap: $268.734M info
PEPG
Nov 10, 2026, 7:05 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.40
Real-time Price: $4.07 info
Change: +$1.67 (+70%) info
Market Cap: $268.734M info
PEPG
Nov 10, 2026, 7:01 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $2.40
Real-time Price: $4.07 info
Change: +$1.67 (+70%) info
Market Cap: $268.734M info
PEPG
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.80
Real-time Price: $4.07 info
Change: +$1.27 (+45%) info
Market Cap: $268.734M info